◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

MustGrow Biologics Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 789,178 2.8M 3.8M 118,836 279,182 --
Operating Revenue 789,178 2.8M 3.8M 118,836 279,182 --
Cost Of Revenue 648,223 2.4M 3.3M 93,522 3,741 --
Gross Profit 140,955 452,028 475,982 25,314 275,441 --
Selling General And Administration 2.2M 1.2M 1.6M 785,180 1.7M --
General And Administrative Expense 1.7M 511,587 840,075 664,962 1.7M --
Research And Development 154,520 81,222 122,301 250,845 93,533 --
Depreciation And Amortization In Income Statement 13,317 13,317 10,808 -- 0.00 0.00
Other Operating Expenses 191,983 136,061 238,155 231,838 170,784 --
Operating Expense 2.6M 1.4M 2.0M 1.3M 2.0M --
Operating Income -2.4M -973,069 -1.5M -1.2M -1.7M --
EBIT -2.4M -1.0M -1.6M -1.2M -1.7M --
Interest Expense 9,168 52,524 42,832 -- 0.00 0.00
Interest Expense Non Operating 9,168 52,524 42,832 -- 0.00 0.00
Interest Income 2,805 4,480 13,697 25,023 46,230 --
Interest Income Non Operating 2,805 4,480 13,697 25,023 46,230 --
Net Interest Income -6,363 -48,044 -96,335 25,023 46,230 --
Other Income Expense -1,355 -67,791 -68,678 4,484 -2,827 --
Gain On Sale Of Security -1,355 -67,791 -68,678 4,484 -2,827 --
Pretax Income -2.4M -1.1M -1.6M -1.2M -1.7M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -2.4M -1.1M -1.6M -1.2M -1.7M --
Net Income From Continuing Operation Net Minority Interest -2.4M -1.1M -1.6M -1.2M -1.7M --
Net Income Including Noncontrolling Interests -2.4M -1.1M -1.6M -1.2M -1.7M --
Net Income Common Stockholders -2.4M -1.1M -1.6M -1.2M -1.7M --
Net Income -2.4M -1.1M -1.6M -1.2M -1.7M --
EBITDA -2.4M -1.0M -1.6M -1.2M -1.7M --
Normalized EBITDA -2.4M -955,272 -1.5M -1.2M -1.7M --
Reconciled Depreciation 13,318 13,317 10,808 -- 0.00 0.00
Basic EPS -0.04 -0.02 -0.03 -- -0.03 -0.02
Diluted EPS -0.04 -0.02 -0.03 -- -0.03 -0.02
Basic Average Shares 54.7M 52.1M 51.6M -- 51.6M 51.6M
Diluted Average Shares 54.7M 52.1M 51.6M -- 51.6M 51.6M
Total Unusual Items -1,355 -67,791 -68,678 4,484 -2,827 --
Total Unusual Items Excluding Goodwill -1,355 -67,791 -68,678 4,484 -2,827 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -2.4M -1.0M -1.6M -1.2M -1.7M --
Depreciation Amortization Depletion Income Statement 13,317 13,317 10,808 -- 0.00 0.00
Depreciation Income Statement 13,317 13,317 10,808 -- 0.00 0.00
Diluted NI Availto Com Stockholders -2.4M -1.1M -1.6M -1.2M -1.7M --
Net Income Continuous Operations -2.4M -1.1M -1.6M -1.2M -1.7M --
Net Non Operating Interest Income Expense -6,363 -48,044 -96,335 25,023 46,230 --
Other Gand A 440,037 455,196 791,355 652,283 345,627 --
Reconciled Cost Of Revenue 648,222 2.4M 3.3M 93,522 3,741 --
Salaries And Wages 1.2M 56,391 48,720 12,679 1.3M --
Selling And Marketing Expense 543,663 682,910 739,937 120,218 85,340 --
Total Expenses 3.2M 3.8M 5.3M 1.4M 2.0M --
Total Other Finance Cost -- -- 67,200 -- -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 3.3M 1.8M 2.0M 3.0M 3.6M --
Cash Cash Equivalents And Short Term Investments 3.3M 1.8M 2.0M 3.0M 3.6M --
Accounts Receivable 182,891 898,017 -- -- -- --
Receivables 182,891 898,017 1.4M 102,776 151,005 --
Inventory 1.9M 1.8M 2.4M 1.4M 408,316 --
Prepaid Assets 272,810 314,278 495,822 129,885 180,884 --
Current Assets 5.7M 4.9M 6.3M 4.7M 4.3M --
Gross PPE 198,794 212,112 225,429 180,264 -- --
Net PPE 198,794 212,112 225,429 180,264 -- --
Goodwill And Other Intangible Assets 187,693 575,575 575,575 575,575 -- --
Total Non Current Assets 386,487 787,687 801,004 755,839 0.00 --
Total Assets 6.1M 5.7M 7.1M 5.4M 4.3M --
Current Debt 417,991 517,991 517,991 393,459 377,063 --
Current Debt And Capital Lease Obligation 432,453 532,133 531,820 393,459 377,063 --
Accounts Payable -- -- -- -- 425,023 --
Payables -- -- -- -- 425,023 --
Payables And Accrued Expenses 2.6M 2.6M 3.2M 2.5M 425,023 --
Current Deferred Revenue -- -- -- 0.00 0.00 272,500
Current Liabilities 3.0M 3.2M 3.7M 2.9M 802,086 --
Long Term Debt 128,436 2.6M 2.6M 124,532 140,928 --
Long Term Debt And Capital Lease Obligation 151,274 2.6M 2.6M 124,532 140,928 --
Long Term Capital Lease Obligation 22,838 26,576 30,231 -- -- --
Total Non Current Liabilities Net Minority Interest 151,274 2.7M 2.7M 350,107 140,928 --
Total Liabilities Net Minority Interest 3.2M 5.9M 6.4M 3.2M 943,014 --
Common Stock 28.3M 25.8M 25.3M 25.3M 25.3M --
Capital Stock 28.3M 25.8M 25.3M 25.3M 25.3M --
Additional Paid In Capital 8.0M 4.9M 5.1M 5.0M 5.0M --
Retained Earnings -33.3M -30.9M -29.8M -28.2M -27.0M --
Common Stock Equity 2.9M -190,396 652,667 2.2M 3.4M --
Stockholders Equity 2.9M -190,396 652,667 2.2M 3.4M --
Total Equity Gross Minority Interest 2.9M -190,396 652,667 2.2M 3.4M --
Total Capitalization 3.0M 2.4M 3.2M 2.3M 3.5M --
Net Tangible Assets 2.7M -765,971 77,092 1.6M 3.4M --
Tangible Book Value 2.7M -765,971 77,092 1.6M 3.4M --
Working Capital 2.7M 1.7M 2.5M 1.8M 3.5M --
Invested Capital 3.5M 2.9M 3.8M 2.7M 3.9M --
Total Debt 583,727 3.1M 3.1M 517,991 517,991 --
Net Debt -- 1.3M 1.1M -- -- --
Share Issued 58.9M 52.4M 51.6M 51.6M 51.6M --
Ordinary Shares Number 58.9M 52.4M 51.6M 51.6M 51.6M --
Capital Lease Obligations 37,300 40,718 44,060 -- -- --
Current Capital Lease Obligation 14,462 14,142 13,829 -- -- --
Current Deferred Liabilities -- -- -- 0.00 0.00 272,500
Finished Goods 1.7M 1.6M 2.2M 1.2M 173,328 --
Other Current Borrowings 417,991 517,991 517,991 393,459 377,063 --
Other Properties 198,794 212,112 225,429 180,264 -- --
Raw Materials 233,337 233,337 233,337 233,337 234,988 --
Taxes Receivable -- -- 1.4M 102,776 151,005 180,549
Tradeand Other Payables Non Current 0.00 71,742 71,742 225,575 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -314,143 -327,025 -3.5M -575,211 -1.1M --
Cash Flow From Continuing Operating Activities -314,143 -327,026 -3.5M -575,211 -1.1M --
Depreciation And Amortization 13,318 13,317 10,808 -- 0.00 0.00
Depreciation Amortization Depletion 13,318 13,317 10,808 -- 0.00 0.00
Stock Based Compensation 1.2M 56,391 48,720 12,679 1.3M --
Change In Working Capital 906,702 633,202 -2.0M 897,652 -448,842 --
Changes In Account Receivables 715,126 459,484 -1.3M -- 29,544 -56,316
Change In Receivables 715,126 459,484 -1.3M 48,229 29,544 --
Change In Inventory -97,059 550,136 -961,019 110,136 -422,672 --
Change In Payables And Accrued Expense 247,167 -557,962 537,998 415,788 69,159 --
Other Non Cash Items -23,881 58,969 75,023 -- -- --
Capital Expenditure -- -- -10,816 -- -- --
Purchase Of PPE 0.00 0.00 -10,816 -- 0.00 0.00
Net PPE Purchase And Sale 0.00 0.00 -10,816 -- 0.00 0.00
Investing Cash Flow 0.00 0.00 -10,816 -- 0.00 0.00
Cash Flow From Continuing Investing Activities 0.00 0.00 -10,816 -- 0.00 0.00
Issuance Of Debt -11,925 0.00 2.6M -- 0.00 0.00
Repayment Of Debt -104,307 -4,307 -1,436 0.00 0.00 --
Net Issuance Payments Of Debt -116,232 -4,307 2.6M 0.00 0.00 --
Financing Cash Flow 1.8M 127,140 2.6M 0.00 0.00 --
Cash Flow From Continuing Financing Activities 1.8M 127,140 2.6M 0.00 0.00 --
Changes In Cash 1.5M -199,885 -976,690 -575,211 -1.1M --
Beginning Cash Position 1.8M 2.0M 3.0M 3.6M 4.7M --
End Cash Position 3.3M 1.8M 2.0M 3.0M 3.6M --
Free Cash Flow -314,143 -327,025 -3.6M -575,211 -1.1M --
Change In Prepaid Assets 41,468 181,544 -365,937 50,999 -124,873 --
Depreciation 13,318 13,317 10,808 -- 0.00 0.00
Long Term Debt Issuance -11,925 0.00 2.6M -- 0.00 0.00
Long Term Debt Payments -104,307 -4,307 -1,436 0.00 0.00 --
Net Income From Continuing Operations -2.4M -1.1M -1.6M -1.2M -1.7M --
Net Long Term Debt Issuance -116,232 -4,307 2.6M 0.00 0.00 --
Proceeds From Stock Option Exercised 0.00 -- -- 0.00 0.00 --
NEWS
Loading news...
TRENDING
Loading...